Willingness-to-pay a better measure to value drugs?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.609, 2010-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Why do Americans pay more for drugs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 601, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Would you pay more for branded drugs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 624, 2011-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Willingness To Pay: What's in a Name?

By Gafni A.

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 465-470

Adis International

Access to resources Recommend Favorite

Reference pricing or HTA for obtaining best value from drugs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Awakenings and Awareness Recovery in Disorders of Consciousness: Is There a Role for Drugs?

By Pistoia Francesca Mura Elisa

CNS Drugs, Vol. 24, Iss. 8, 2010-08 ,pp. : 625-638

Adis International

Access to resources Recommend Favorite